219 related articles for article (PubMed ID: 36615764)
1. The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects.
Alwadani AH; Almasri SA; Aloud AA; Albadr NA; Alshammari GM; Yahya MA
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615764
[TBL] [Abstract][Full Text] [Related]
2. Esculeogenin A, a Glycan from Tomato, Alleviates Nonalcoholic Fatty Liver Disease in Rats through Hypolipidemic, Antioxidant, and Anti-Inflammatory Effects.
Al Jadani JM; Albadr NA; Alshammari GM; Almasri SA; Alfayez FF; Yahya MA
Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004149
[TBL] [Abstract][Full Text] [Related]
3. Activation of AMPK Entails the Protective Effect of Royal Jelly against High-Fat-Diet-Induced Hyperglycemia, Hyperlipidemia, and Non-Alcoholic Fatty Liver Disease in Rats.
Felemban AH; Alshammari GM; Yagoub AEA; Al-Harbi LN; Alhussain MH; Yahya MA
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986201
[TBL] [Abstract][Full Text] [Related]
4. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).
Wang Z; Li S; Wang R; Guo L; Xu D; Zhang T; Xu Y; Wang W; Wang M; Gan Z; Wang X
Mol Med; 2020 Jun; 26(1):54. PubMed ID: 32503411
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of ursodeoxycholic acid, resveratrol, and N-acetylcysteine on nonalcoholic fatty liver disease in rats.
Ali MH; Messiha BA; Abdel-Latif HA
Pharm Biol; 2016 Jul; 54(7):1198-208. PubMed ID: 26134756
[TBL] [Abstract][Full Text] [Related]
6. Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXRα and PPARα.
Zhang R; Yu Y; Hu S; Zhang J; Yang H; Han B; Cheng Y; Luo X
Nutr Res; 2016 Sep; 36(9):1022-1030. PubMed ID: 27632923
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of neomangiferin on high fat diet-induced nonalcoholic fatty liver disease in rats.
Zhou C; Zhou J; Han N; Liu Z; Xiao B; Yin J
Int Immunopharmacol; 2015 Mar; 25(1):218-28. PubMed ID: 25661699
[TBL] [Abstract][Full Text] [Related]
8. The Hepatic Antisteatosis Effect of Xanthohumol in High-Fat Diet-Fed Rats Entails Activation of AMPK as a Possible Protective Mechanism.
Atteia HH; AlFaris NA; Alshammari GM; Alamri E; Ahmed SF; Albalwi R; Abdel-Sattar SA
Foods; 2023 Nov; 12(23):. PubMed ID: 38231665
[TBL] [Abstract][Full Text] [Related]
9. Prenatal ethanol exposure programs an increased susceptibility of non-alcoholic fatty liver disease in female adult offspring rats.
Shen L; Liu Z; Gong J; Zhang L; Wang L; Magdalou J; Chen L; Wang H
Toxicol Appl Pharmacol; 2014 Jan; 274(2):263-73. PubMed ID: 24275070
[TBL] [Abstract][Full Text] [Related]
10. Astaxanthin attenuates hepatic steatosis in high-fat diet-fed rats by suppressing microRNA-21 via transactivation of nuclear factor erythroid 2-related factor 2.
Shatoor AS; Al Humayed S; Almohiy HM
J Physiol Biochem; 2022 Feb; 78(1):151-168. PubMed ID: 34651285
[TBL] [Abstract][Full Text] [Related]
11. The hepatoprotective effects of n3-polyunsaturated fatty acids against non-alcoholic fatty liver disease in diabetic rats through the FOXO1/PPARα/GABARAPL1 signalling pathway.
Ramadan NM; Elmasry K; Elsayed HRH; El-Mesery A; Eraky SM
Life Sci; 2022 Dec; 311(Pt A):121145. PubMed ID: 36336129
[TBL] [Abstract][Full Text] [Related]
12. Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.
Lee H; Ahn J; Shin SS; Yoon M
Int J Obes (Lond); 2019 Aug; 43(8):1620-1630. PubMed ID: 30283077
[TBL] [Abstract][Full Text] [Related]
13. Zingerone ameliorates non-alcoholic fatty liver disease in rats by activating AMPK.
Mohammed HM
J Food Biochem; 2022 Jul; 46(7):e14149. PubMed ID: 35338494
[TBL] [Abstract][Full Text] [Related]
14. Water extract from artichoke ameliorates high-fat diet-induced non-alcoholic fatty liver disease in rats.
Deng A; Liu F; Tang X; Wang Y; Xie P; Yang Q; Xiao B
BMC Complement Med Ther; 2022 Nov; 22(1):308. PubMed ID: 36424606
[TBL] [Abstract][Full Text] [Related]
15. Exogenous administration of unacylated ghrelin attenuates hepatic steatosis in high-fat diet-fed rats by modulating glucose homeostasis, lipogenesis, oxidative stress, and endoplasmic reticulum stress.
Alharbi S
Biomed Pharmacother; 2022 Jul; 151():113095. PubMed ID: 35594708
[TBL] [Abstract][Full Text] [Related]
16. Salidroside inhibits insulin resistance and hepatic steatosis by downregulating miR-21 and subsequent activation of AMPK and upregulation of PPARα in the liver and muscles of high fat diet-fed rats.
Almohawes ZN; El-Kott A; Morsy K; Shati AA; El-Kenawy AE; Khalifa HS; Elsaid FG; Abd-Lateif AM; Abu-Zaiton A; Ebealy ER; Abdel-Daim MM; Ghanem RA; Abd-Ella EM
Arch Physiol Biochem; 2024 Jun; 130(3):257-274. PubMed ID: 35061559
[TBL] [Abstract][Full Text] [Related]
17. Eugenol modulates insulin sensitivity by upregulating insulin receptor substrate-2 in non-alcoholic fatty liver disease in rats.
Fawzy MH; Saeed NM; El-Sherbiny DA; El-Demerdash E
J Pharm Pharmacol; 2021 Apr; 73(6):846-854. PubMed ID: 33822104
[TBL] [Abstract][Full Text] [Related]
18. The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Gao H; Zeng Z; Zhang H; Zhou X; Guan L; Deng W; Xu L
Biol Pharm Bull; 2015; 38(5):694-702. PubMed ID: 25947915
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
Wang Y; Li JY; Han M; Wang WL; Li YZ
Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
[TBL] [Abstract][Full Text] [Related]
20. NLRP3 inhibitor glibenclamide attenuates high-fat diet and streptozotocin-induced non-alcoholic fatty liver disease in rat: studies on oxidative stress, inflammation, DNA damage and insulin signalling pathway.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2020 Apr; 393(4):705-716. PubMed ID: 31834465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
